Using Factor VII in Hemophilia Gene Therapy

نویسندگان

  • Bahram Kazemi
  • Shahid Beheshti
چکیده

Human blood at physiological conditions is kept as fluid through precise system called homeostasis, if damage to the vessel, causing the system will be restored by vessel wall. Cases no regulation or homeostasis disorders, thrombosis (intravascular coagulation) or bleeding occur. In normal conditions, the secretion of vascular endothelial heparin-like and trmbomodulin molecules prevent blood coagulation and secretion of nitric oxide and prostacyclin prevent platelet aggregation and blood brings the liquid keeps. Homeostasis has three stages: vasoconstriction, platelet plug formation and blood coagulation, blood coagulation are reactions in which plasma zymogens become active enzymes that create the clotting reaction. Coagulation reactions will be set with inhibitory and stimulatory mechanisms. Coagulation is a regulatory process that keeps the blood flowing. Blood coagulation has two external and internal pathways (Figure 1), tissue factor and FVII form the external pathway, internal pathway is formed of FVIII, FIX and FXI (Ramanarayana et al., 2011; Ellison, 1977).

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

کلونینگ cDNA فاکتور VII انعقادی حاصل از رده سلولی هپاتوما

Abstract Background: Factor VII, is a coagulant protease it begins the proteolytic cascade reactions and produces thrombin. The use of recombinant human factor VII, (rhFVII) is effective for the treatment of patients with hemophilia A or B. It is a target for gene therapy. This study was done to clone factor VII from HepG2 cell line. Methods: RNA was extracted from the hepatoma, (HepG2), ...

متن کامل

Expression of Recombinant Coagulation Factor IX in Human Amniotic Membrane-derived Mesenchymal Stem Cells: A New Strategy to Gene Therapy of Hemophilia B

Background: Hemophilia B is an X-linked hereditary disorder of blood coagulation system which is caused by factor IX (FIX) deficiency. Factor IX is a plasma glycoprotein that participates in the coagulation process leading to the generation of fibrin. Replacement of factor IX with plasma-derived or recombinant factor IX is the conventional treatment for hemophilia B to raise the factor IX le...

متن کامل

Recent Advances in Hemophilia Gene Therapy

Heterogeneous loss of function mutations at F8 and F9 genes causes X-linked recessive bleeding disorders, hemophilia A (HA) and hemophilia B (HB), respectively. HA is clinically indistinguishable from HB and accounts for more than 80% of hemophilia cases; the former affects 1/5000 and the latter 1/25000 male births worldwide. In Iran, it is estimated that around 4300 HA and 900 HB patients are ...

متن کامل

Preparation of factor VII concentrate using CNBr-activated

  Background: Factor VII concentrates are used in patients with congenital or acquired factor VII deficiency or treatment of hemophilia patients with inhibitors. In this research, immunoaffinity chromatography was used to purify factor VII from prothrombin complex (Prothrombin-Proconvertin-Stuart Factor-Antihemophilic Factor B or PPSB) which contains coagulation factors II, VII, IX and X. The a...

متن کامل

Engineered Factor VII, Factor IX, and Factor X Variants for Hemophilia Gene Therapy

The coagulation factors VII, IX, and X are all vitamin K dependent serine proteases synthesized in the liver with a high degree of similarity concerning size and structure. Factor IX is the deficient protein in hemophilia B and used in substitution therapy. The activated form of factor VII (FVIIa) is used to treat hemophilia in which the coagulant tenase complex cannot form due to inhibitory an...

متن کامل

Gene Expression under F8 Promoter Driving In Mouse Hepatoma Cells: A Step towards Gene Therapy of Hemophilia

Background and Objectives: Significant progress has been made in treatment of hemophilia. Ex-vivo gene therapy is going popular due to the capability of this method in using isogenic cells for genetic manipulation and reintroducing them into same host after proliferation. Most gene therapy techniques use viral vectors, which usually harbor a strong and non-specific promoter (e...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2012